Clinical Trials Browser

Phase 3 × Pathologic Complete Response × pirarubicin × Clear all

NCT02613026 2015-11-24

Comparative Analysis of the Efficacies in Neoadjuvant Chemotherapy of Breast Cancer

Phase 3 Completed

Pathologic Complete Response, Breast Neoplasms